Design, synthesis and evaluation of quinazoline derivatives as Gαq/11 proteins inhibitors against uveal melanoma
- 28 November 2023
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 143, 107005
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (22077144, 82373722)
- Special Project for Research and Development in Key areas of Guangdong Province (2020B1111110003)
- Guangdong Provincial Key Laboratory of Construction Foundation (2023B1212060022)
- Basic and Applied Basic Research Foundation of Guangdong Province (2023B1515040006)
This publication has 28 references indexed in Scilit:
- YAP inhibition blocks uveal melanogenesis driven by GNAQ or GNA11 mutationsMolecular & Cellular Oncology, 2014
- GNAQ and GNA11 mutations in uveal melanomaMelanoma Research, 2014
- Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in ChinesePLOS ONE, 2014
- Development of inhibitors of heterotrimeric Gαi subunitsBioorganic & Medicinal Chemistry, 2014
- The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancerNature Reviews Cancer, 2013
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphineEuropean Journal of Pharmacology, 2008
- Heterotrimeric G protein activation by G-protein-coupled receptorsNature Reviews Molecular Cell Biology, 2008
- Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric Gα/Gβγ Protein ComplexCancer Research, 2006
- Uveal Melanoma: Epidemiologic AspectsOphthalmology Clinics of North America, 2005